0041 - 79 938 95 71      info@venartis.org      drragg

Biomatrix Sclerofoam

Common homemade sclerofoams lose their effectiveness as the vein diameter increases. The foam will float on blood, distributing in uncontrolled patterns, requiring several injection sessions. Thus, sclerotherapy is inferior to thermal occlusion. We showed this correlation in 2005 in a small (and soon abandoned) series of cases which had laser treatment of a 10 cm GSV junction segment combined with GSV microfoam below. Yes, it is time saving - but at clearly inferior rates of primary and long-term success.
As far as data is known from the newly approved ‘Varithena’ microfoam (BTG), this method does not solve the problem of low foam viscosity, short half-life and suboptimal clinical effects.
Currently we are developing a completely different sclerofoam with a variable viscosity for clinical use in saphenous veins with a very long half-life but rapid disintegration when exceeding junction levels. The difference is based on physical (not chemical) aspects. Due to this main feature, clinical application was feasible in a few selected cases, indicating effectiveness levels equal to radiofrequency.
A controlled clinical multicenter study started in 2016.



Literature follows...

See some photos from recent Workshops

Please, enter your name
Please, enter your phone number (must start with 0 or +)
Please, enter your e-mail address Mail address is not not valid
Please, enter your message

About us

I have been working on innovations in venous medicine now for 17 years, together with my teams in Berlin, Munich and Zurich and a growing number of international friends.

My personal bio includes physics, interventional radiology, angiology, phlebology and meanwhile 27 years of clinical experience in interdisciplinary vascular medicine

Award Sponsors

All prizes are offered by the VENARTIS work group, from the private pocket of cooperating physicians.

The committee selecting the innovation award winner includes members of vWIN foundation and VENARTIS work group.


Work Group Dr. Ragg

c/o Swiss-VX Venentherapie
und Forschung GmbH
Chaltenbodenstrasse 16
CH - 8834 Schindellegi (SZ)
0041 - 79 938 95 71